IRIS
SALOMONE, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.742
EU - Europa 4.860
AS - Asia 4.599
SA - Sud America 813
AF - Africa 577
Continente sconosciuto - Info sul continente non disponibili 375
OC - Oceania 12
Totale 20.978
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.366
SG - Singapore 2.341
RU - Federazione Russa 1.450
CN - Cina 1.230
IT - Italia 1.090
IE - Irlanda 729
BR - Brasile 643
UA - Ucraina 616
VN - Vietnam 406
CA - Canada 286
CI - Costa d'Avorio 252
FR - Francia 244
DE - Germania 187
SN - Senegal 130
SE - Svezia 120
KR - Corea 102
GB - Regno Unito 100
IN - India 98
NG - Nigeria 91
BD - Bangladesh 67
FI - Finlandia 54
HK - Hong Kong 49
AR - Argentina 47
MX - Messico 42
PL - Polonia 38
ID - Indonesia 37
NL - Olanda 37
JP - Giappone 36
ZA - Sudafrica 33
IQ - Iraq 32
CO - Colombia 31
ES - Italia 31
TR - Turchia 30
PK - Pakistan 28
EC - Ecuador 27
GR - Grecia 25
BE - Belgio 23
UZ - Uzbekistan 23
VE - Venezuela 22
CH - Svizzera 20
KE - Kenya 20
IR - Iran 18
AT - Austria 15
PY - Paraguay 15
JM - Giamaica 14
MA - Marocco 14
CZ - Repubblica Ceca 13
AU - Australia 11
AZ - Azerbaigian 11
LB - Libano 11
AL - Albania 9
JO - Giordania 9
SA - Arabia Saudita 9
TN - Tunisia 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
BG - Bulgaria 8
CL - Cile 8
EG - Egitto 8
LT - Lituania 8
BJ - Benin 7
EU - Europa 7
IL - Israele 7
TH - Thailandia 7
HR - Croazia 6
PH - Filippine 6
RO - Romania 6
RS - Serbia 6
BA - Bosnia-Erzegovina 5
CR - Costa Rica 5
GT - Guatemala 5
PA - Panama 5
PE - Perù 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
MY - Malesia 4
OM - Oman 4
SI - Slovenia 4
GA - Gabon 3
MD - Moldavia 3
NP - Nepal 3
PR - Porto Rico 3
PS - Palestinian Territory 3
QA - Qatar 3
AO - Angola 2
BY - Bielorussia 2
CY - Cipro 2
ET - Etiopia 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MN - Mongolia 2
NI - Nicaragua 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
AD - Andorra 1
Totale 20.593
Salva come PNG Salva come JPEG
Città #
Dallas 1.429
Singapore 1.336
Santa Clara 1.058
Chandler 916
Dublin 728
Jacksonville 689
Moscow 596
San Jose 581
Ashburn 462
Chicago 340
Boardman 325
Catania 292
Abidjan 252
Cambridge 201
Lawrence 198
Beijing 196
Andover 195
Houston 182
Lauterbourg 181
Nanjing 180
Toronto 175
Hefei 164
Los Angeles 162
Dakar 130
Ho Chi Minh City 114
Wilmington 110
Seoul 101
Council Bluffs 99
Hanoi 88
Des Moines 87
Civitanova Marche 83
San Mateo 83
New York 80
Dong Ket 65
Shenyang 63
Nanchang 62
São Paulo 57
Grafing 53
Hebei 51
Ottawa 49
The Dalles 49
Bremen 47
Buffalo 47
Columbus 45
Messina 45
Saint Petersburg 45
Abuja 43
Hong Kong 41
Changsha 38
Jiaxing 35
Lagos 35
Orem 35
Milan 33
Palermo 32
Munich 31
Tokyo 31
Tianjin 30
Atlanta 28
Rome 28
Falls Church 27
Montreal 27
Seattle 27
Rio de Janeiro 26
Brooklyn 25
Warsaw 25
Helsinki 24
Dearborn 22
Amsterdam 20
Chennai 20
Denver 19
Florence 19
Johannesburg 19
Norwalk 19
Stockholm 19
Jakarta 18
Boston 17
Phoenix 17
Redwood City 17
Brussels 16
Curitiba 16
Jinan 16
Pune 16
Turku 16
Lissone 15
Poplar 15
Washington 15
Baghdad 14
Belo Horizonte 14
Da Nang 14
Guangzhou 13
Hangzhou 13
Nairobi 13
Port Harcourt 13
San Francisco 13
Kunming 12
Lahore 12
Liberty Lake 12
London 12
Miami 12
Mumbai 12
Totale 13.642
Salva come PNG Salva come JPEG
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 298
Current drug treatments targeting dopamine D3 receptor 248
Dopaminergic-GABAergic interplay and alcohol binge drinking 239
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 227
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 224
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 190
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 189
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 188
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 186
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 186
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 184
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 180
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 178
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 177
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 167
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 166
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 165
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 164
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 159
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats 158
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 155
Particle identification with the 4 pi CHIMERA detector array 154
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 152
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 151
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 148
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 147
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders 144
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 144
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 143
Controversies in Glaucoma: Current Medical Treatment and Drug Development 142
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 142
Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications 136
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 136
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 134
Activity of dihydrothienopyridine S312 enantiomers on L-type calcium channels in isolated rat aorta and cerebral microvessels 133
Epigenetic drugs for Alzheimer's disease: hopes and challenges 133
Pericyte-like differentiation of human adipose-derived mesenchymal stem cells: An in vitro study 133
Effects of phenformin on the proliferation of human tumor cell lines 132
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 131
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 130
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy 129
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 129
Retinal protection and distribution of curcumin in vitro and in vivo 129
Antipsychotic dose reduction compared to dose continuation for people with schizophrenia 129
Evaluation of Neostigmine responsiveness with concentric-needle single fiber electromyography in myasthenia gravis: A comparative study 128
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 128
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 127
Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes 126
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 126
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin 125
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 123
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 123
P2X7 receptor antagonism: implications in diabetic retinopathy 122
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 121
Linking the Price of Cancer Drug Treatments to Their Clinical Value 120
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 120
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 119
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 119
Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? 119
Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment 118
A THERAPEUTIC DOSAGE OF AMLODIPINE PREVENTS VASCULAR HYPOREACTIVITY INDUCED IN RATS BY LIPOPOLYSACCHARIDE 118
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 118
Abnormal vascular responses and cerebral reperfusion injury in ApoE-deficient mice on Western diet 117
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE 117
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 116
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 115
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools 114
Isoflavones: estrogenic activity, biological effect and bioavailability 113
Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network 111
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 111
Analytical and experimental pharmacology, challenges ahead 110
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 109
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 108
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 107
An Italian Guidance Model for the Management of Suspected or Confirmed COVID-19 Patients in the Primary Care Setting 107
Effects of Topical Fucosyl-Lactose, a Milk Oligosaccharide, on Dry Eye Model: An Example of Nutraceutical Candidate 106
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 106
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 105
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 105
Pharmacological and genetic evidence of dopamine receptor 3-mediated vasoconstriction in isolated mouse aorta 103
Lipoprotein(a) serum levels in diabetic patients with retinopathy 103
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 103
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 102
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 102
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats 102
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 102
Pleiotropic effects of glitazones: a double edge sword? 101
Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery 101
Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine 101
Genomic portrait of a sporadic amyotrophic lateral sclerosis case in a large spinocerebellar ataxia type 1 family 101
Preclinical study of the action of a calcium channel blocker during salt load 98
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 97
CALCIUM ANTAGONISTS AND ENDOTHELIAL FUNCTION: FOCUS ON NITRIC OXIDE AND ENDOTHELIN 95
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis 95
New pharmacological strategies for treatment of Alzheimer’s disease: focus on disease-modifying drugs 94
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors 93
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium 93
New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: Focus on brexpiprazole and pimavanserin 93
MicroRNA target prediction in glaucoma 92
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1 91
Totale 13.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.351 0 211 28 25 227 53 217 57 148 8 59 318
2022/20232.734 232 124 40 279 277 463 30 511 621 15 88 54
2023/2024992 60 149 54 73 36 208 17 62 8 17 187 121
2024/20254.022 51 626 214 248 911 464 115 174 297 389 282 251
2025/20268.329 463 365 1.550 521 1.314 1.622 1.000 170 411 436 327 150
2026/2027231 225 6 0 0 0 0 0 0 0 0 0 0
Totale 20.978